---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-050025"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2024-12-13T23:59:59+00:00"
generated_at: "2026-05-29T03:26:26.623186+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics updates ATM offering limit to $832,009 after $846k previously sold

## Summary
- Filed prospectus supplement resetting ATM with H.C. Wainwright to max $832,009 in common shares.
- Previously sold approximately $846,288 under September 27, 2024 prospectus supplement.
- Shares offered under Sales Agreement dated September 27, 2024 with H.C. Wainwright & Co.
- Legal opinion from Harter Secrest & Emery LLP on share legality filed as Exhibit 5.1.

## SEC filing metadata
- accession: 0001493152-24-050025
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2024-12-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315224050025/0001493152-24-050025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315224050025/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-050025
- JSON: https://secwatch.observer/filing/0001493152-24-050025.json
- Plain text: https://secwatch.observer/filing/0001493152-24-050025.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.